Results for tag: "Integrase Inhibitors"

Integrase inhibitors are a class of antiretroviral drugs used to treat HIV/AIDS. They work by blocking the action of the HIV-1 integrase enzyme, which is responsible for the integration of the viral DNA into the host cell's genome. This prevents the virus from replicating and spreading throughout the body. Integrase inhibitors are generally used in combination with other antiretroviral drugs to maximize their effectiveness. Integrase inhibitors are an important part of the HIV/AIDS treatment landscape, as they are effective at suppressing the virus and reducing the risk of HIV-related complications. They are also well-tolerated, with few side effects. Some companies in the Integrase Inhibitors market include Gilead Sciences, ViiV Healthcare, Merck, and Janssen Pharmaceuticals. Show Less Read more